Skip to main content
Clinical Trials/NCT05206500
NCT05206500
Recruiting
Phase 4

Clinical Implication of Next Generation Sequencing of Urinary Bacteria in Patients With Low Colony Forming Units of Bacteria in Traditional Urine Culture

Wake Forest University Health Sciences1 site in 1 country100 target enrollmentMay 17, 2022

Overview

Phase
Phase 4
Intervention
Antibiotic
Conditions
Urinary Tract Infections
Sponsor
Wake Forest University Health Sciences
Enrollment
100
Locations
1
Primary Endpoint
Next Generation Sequencing (NGS) Results (numbers of colony count (CC)) of Urinary Tract Infection (UTI)
Status
Recruiting
Last Updated
4 months ago

Overview

Brief Summary

Recently more advanced techniques, including Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) are available to detect bacteria in urine based on bacterial genomes. Comparing to traditional culture, these techniques have more sensitivity and could potentially be of a great help in patients with Colony Count of less than 10,000 and more than zero.

Detailed Description

Bacterial sensitivity test for different antibiotics are the most important guide for treatment of patients with UTI. Unfortunately, for patients with less than 10,000 Colony Count (CC), usually no sensitivity test is done and there is not any guide for appropriate antibiotic therapy for this group.

Registry
clinicaltrials.gov
Start Date
May 17, 2022
End Date
December 1, 2028
Last Updated
4 months ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Female at least 18 years of age
  • U/C (Urinary Culture) growth of \<10,000 Colony-Forming Units (CFU)
  • Understanding and acceptance of the need to return for all scheduled follow-up visits
  • Able to give informed consent

Exclusion Criteria

  • Catheter in use (Foley or suprapubic or intermittent)
  • Not able to provide clean midstream urine
  • Antibiotic consumption in the past 2 weeks before signing the consent
  • Pregnant or Planning to Conceive
  • Incarcerated

Arms & Interventions

Symptomatic Patients with low Colony Count

Patients with positive urinalysis, symptomatic, and Urine Culture Colony Count \<10,000 to be treated based on Next Generation Sequencing result.

Intervention: Antibiotic

Symptomatic Patients with low Colony Count

Patients with positive urinalysis, symptomatic, and Urine Culture Colony Count \<10,000 to be treated based on Next Generation Sequencing result.

Intervention: Next Gen

Outcomes

Primary Outcomes

Next Generation Sequencing (NGS) Results (numbers of colony count (CC)) of Urinary Tract Infection (UTI)

Time Frame: 3 Weeks Post-Treatment

NGS Ability to Detect Bacteria among patients with UTI Colony Count (CC) of Bacteria \<10,000, Result Measure: NGS CC 100 to 10,000

Secondary Outcomes

  • Patient Improvement (King's Questionnaire Outcome measure) in UTI symptoms with CC <10,000(3 Weeks Post-Treatment)

Study Sites (1)

Loading locations...

Similar Trials